ANZCTR - Registration

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers

Trial registered on ANZCTR

Registration number

ACTRN12618000187246

Ethics application status

Approved

Date submitted

31/01/2018

Date registered

5/02/2018

Date last updated

22/02/2019

Date data sharing statement initially provided

22/02/2019

Type of registration

Prospectively registered

Titles & IDs

Public title

Comparing short sighted refraction profiles created by two different designs of an orthokeratology contact lens

Scientific title

Changes in peripheral optics with two different orthokeratology lens designs for patients with myopia

Secondary ID [1]

None

Universal Trial Number (UTN)

Trial acronym

Linked study record

Health condition

Health condition(s) or problem(s) studied:

Myopia

Condition category

Condition code

Eye

Diseases / disorders of the eye

Intervention/exposure

Study type

Interventional

Description of intervention(s) / exposure

Two different orthokeratology lens designs are to be worn in randomised order for a period of 1 week overnight wear each, after which purposely induced changes to corneal shape and associated effect on refraction profile will be measured and compared, with a minimum 1 week duration washout period between the two iterations where no lenses will be worn. Each iteration will be worn overnight only in both eyes for a minimum of 5 hours and maximum of 12 hours.The orthokeratology lenses will be fitted by university researchers under the direct supervision of qualified University of New South Wales (UNSW), Sydney, employed optometrists. Participants will be required to self insert the lenses at their home before sleep and remove them on waking, with all training and support on how to insert and remove lenses and deal with any lens adherence provided. After each week of overnight wear participants will be required to return to UNSW for study measurements. Participants will be required to attend the study centre after the first night of lens wear to assess lens fit and to ensure that participants are successful in removing the lenses and in taking the correct cleaning and storage steps unguided. Participants will not be allowed to continue with the study until they are competent at removing and caring for the lenses without guidance. In the unlikely case that a participant has found the lens to be bound and can't be loosened with the resolution steps provided they will be instructed to contact the investigators for advice.

Intervention code [1]

Treatment: Devices

Comparator / control treatment

Double blind repeated measures design with each of the two orthokeratology lens designs issued for wear in a randomised order. No need for a control group.

Control group

Active

Outcomes

Primary outcome [1]

Changes to anterior eye shape profile will be measured using a Medmont E300 corneal topographer.

Timepoint [1]

In the morning before starting wear and in the morning after 7 nights of wear for each of the two orthokeratology lens designs being investigated.

Secondary outcome [1]

Changes to peripheral refraction will be measured across the horizontal meridian using the Shin_Nippon NVisionK 5001 autorefractor

Timepoint [1]

In the morning before starting wear and in the morning after 7 nights of wear for each of the two orthokeratology lens designs being investigated.

Eligibility

Key inclusion criteria

1. Healthy individuals aged between 18-40
2. Have short-sightedness (myopia) between -1.ooD and -4.ooD and less than -1.50D of corneal astigmatism
3. No previous rigid contact lens wear
4. Have good ocular health and general health
5. No contraindications to rigid contact lens wear

Minimum age

18 Years

Maximum age

40 Years

Sex

Both males and females

Can healthy volunteers participate?

Key exclusion criteria

1. Strabismus or amblyopia
2. Systemic or ocular conditions that may affect tear quality or contact lens wear or that may affect refractive development
3. Previous history or ocular surgery, trauma, or chronic ocular disease
4. Ocular or systemic medication use that may interfere with contact lens wear or ocular surface
5. Not willing to comply with the allocated treatment and follow-up scheduole

Study design

Purpose of the study

Treatment

Allocation to intervention

Randomised controlled trial

Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)

The order of wear for the two orthokeratology lens designs will be controlled by off-site by the contact lens lab providing the lenses. The lab will issue both sets of orthokeratology lenses in identical packets other than one being marked 'first to be worn' and the other 'second to be worn'. Order of allocation will be recorded by the lab and issued to the researcher conducting data analysis once all participants have completed the study. For an additional layer of clarification each orthokeratology lens will be engraved by the lab with a unique number that will be recorded by the researcher recording the study measurements so that at data analysis stage the lenses actually worn according to researcher observation can be cross referenced to the lens supply schedule recorded by the lab.

Methods used to generate the sequence in which subjects will be randomised (sequence generation)

Simple randomisation using a randomisation table created by computer software.

Masking / blinding

Blinded (masking used)

Who is / are masked / blinded?

The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes

Intervention assignment

Crossover

Other design features

Phase

Not Applicable

Type of endpoint/s

Efficacy

Statistical methods / analysis

Prior data indicate that to conduct a study that is able to detect a difference of 0.1 D in mid-peripheral corneal refractive power, with a study power of 0.80 at the 5% level of statistical significance and taking into consideration a 20% drop out rate, 15 subjects will be required for this study. The Type I error probability associated with this test of this null hypothesis is 0.05. Repeated measures t-tests will be used to compare change to corneal shape profile and peripheral refraction profile over the 1 week wearing period of overnight wear between the two orthokeratology lens designs.

Recruitment

Recruitment status

Completed

Date of first participant enrolment

Anticipated

26/02/2018

Actual

8/05/2018

Date of last participant enrolment

Anticipated

Actual

30/11/2018

Date of last data collection

Anticipated

Actual

17/12/2018

Sample size

Target

Accrual to date

Final

Recruitment in Australia

Recruitment state(s)

NSW

Funding & Sponsors

Funding source category [1]

University

Name [1]

University of New South Wales

Address [1]

School of Optometry and Vision Science, University of New South Wales, Gate 14, Barker St, Rupert Myers Building (North Wing), Kensington, NSW, 2033

Country [1]

Australia

Primary sponsor type

University

Name

University of New South Wales

Address

School of Optometry and Vision Science, University of New South Wales, Gate 14, Barker St, Rupert Myers Building (North Wing), Kensington, NSW, 2033

Country

Australia

Secondary sponsor category [1]

None

Name [1]

Address [1]

Country [1]

Ethics approval

Ethics application status

Approved

Ethics committee name [1]

UNSW Human Research Ethics Committee

Ethics committee address [1]

UNSW Research Ethics & Compliance Support 
University of New South Wales 
Gate 14, Barker St 
Rupert Myers Building (South Wing) 
Kensington, NSW, 2033

Ethics committee country [1]

Australia

Date submitted for ethics approval [1]

05/02/2018

Approval date [1]

08/03/2018

Ethics approval number [1]

HC17954

Summary

Brief summary

Myopia (short sightedness) is a refractive condition where the distance from the front to the back of the eye is too long for the refractive strength of the eye, leading to light being focussed in front of the retina (light sensitive layer on the inside back of the eye) and subsequently causing blurred vision. Myopia typically develops in childhood while the eye is growing and is believed to be accelerated by correcting the myopia with glasses. When myopia first presents the child complains of poor distance vision which is corrected by glasses. Unfortunately, myopia continues to progress requiring the child to return at regular intervals to get ever stronger glasses, until they reach adulthood.

Orthokeratology (OK) lenses are specialised contact lenses that are worn during sleep to reshape the front surface of the eye to temporarily correct myopia. Recent research has shown that OK lenses are effective at slowing progression of myopia by 50%. These encouraging results have led contact lens manufacturers to develop OK lens designs with greater effectivity in slowing progression of myopia. While these ‘Myopia Control’ OK lenses are now being supplied to optometry practices and marketed as being more effective in slowing progression of myopia compared to standard OK lens designs, there is no scientific evidence to support that they are any more effective than standard OK designs. 

The aim of this project is to increase understanding on how myopia control OK lens designs will affect known stimuluses for myopia progression compared to standard OK lens designs. The scientific literature reveals that OK causes peripheral light rays to be focussed further towards the front of the eye than central light rays, which is termed peripheral myopic defocus. Peripheral myopic defocus has been shown to slow progression of myopia in animal models, and this same mechanism is believed to be the reason why OK lenses slow progression of myopia. The manufacturers of myopia control OK lens designs claim that they are more effective at slowing progression of myopia compared to standard OK lens designs because they create a greater amount of peripheral myopic defocus. 

We are going to investigate the potential for greater slowing of myopia progression with myopia control OK lens designs, by measuring the effect that the different OK designs have on myopic defocus in young adults over 1 week of wear, which is the reported shortest duration of time for the full refractive effect to be achieved. This study is important as optometrists need to know the true effect that OK lenses marketed to slow myopia progression have on refractive mechanisms that have been shown to retard progression of myopia, if they are to be effective in managing myopia in their child patients. Outcomes will also assist the design of future longitudinal studies using standard and myopia control OK lens designs.

Trial website

Trial related presentations / publications

Public notes

Contacts

Principal investigator

Name

Dr Paul Gifford

Address

School of Optometry and Vision Science University of New South Wales
Gate 14, Barker St
Rupert Myers Building (North Wing) Kensington, NSW, 2033

Country

Australia

Phone

+61423489596

Fax

p.gifford@unsw.edu.au

Contact person for public queries

Name

Paul Kang

Address

School of Optometry and Vision Science University of New South Wales
Gate 14, Barker St
Rupert Myers Building (North Wing) Kensington, NSW, 2033

Country

Australia

Phone

+61 2 9385 9816

Fax

p.kang@unsw.edu.au

Contact person for scientific queries

Name

Paul Gifford

Address

School of Optometry and Vision Science University of New South Wales
Gate 14, Barker St
Rupert Myers Building (North Wing) Kensington, NSW, 2033

Country

Australia

Phone

+61423489596

Fax

p.gifford@unsw.edu.au

Data sharing statement

Will individual participant data (IPD) for this trial be available (including data dictionaries)?

No/undecided IPD sharing reason/comment

Subject data is de-personalised.

What supporting documents are/will be available?

No Supporting Document Provided

Results publications and other study-related documents

Documents added manually

No documents have been uploaded by study researchers.

Documents added automatically

No additional documents have been identified.

Trial Review

Registering a new trial?

Documents added manually

Documents added automatically